Know Cancer

or
forgot password
  • cancer clinical trials in dallas, TX

  • Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas 75235-8897
    Pancreatic Cancer
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    Baylor Sammons Cancer Center
    Dallas, Texas 75246
    Follicular Lymphoma
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Dallas Surgical Group

    Trial Locations
    Dallas Surgical Group
    Texas Health
    Breast Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    Baylor Research Institute
    Dallas, Texas 75246
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
    University of Texas at Southwestern
    Dallas, Texas
    Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Texas Oncology-Dallas Presbyterian Hospital

    Trial Locations
    Texas Oncology-Dallas Presbyterian Hospital
    Texas Oncology-Baylor Charles A. Sammons Cancer Center
    Texas Oncology-Medical City Dallas
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer
    Texas Oncology, P.A. Dept.ofTexas Oncology, PA
    Dallas, Texas 75246
    Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC)
    A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
    Baylor Research Institute
    Dallas, Texas 75246
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component, Recurrent Glioblastoma, Relapsed Glioblastoma
    Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
    Texas Oncology
    Dallas, Texas
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Hodgkins Disease, Non-Hodgkins Lymphoma, Aplastic Anemia, Multiple Myeloma, Myelodysplastic Syndrome
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    University of Texas Southwestern Medical Center
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Advanced Cancer, Metastatic Cancer, Solid Tumors
    Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Colon Cancer
    Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
    Texas Oncology, PA (North)
    Dallas, Texas 75246
    Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
    Phase II Study of Crenolanib in Subjects With Relapsed AML With FLT3-D835 Activating Mutations
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Relapsed or Refractory Acute Myeloid Leukemia With FLT3-D835 Activating Mutations
    Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
    US Oncology Central Monitoring

    Trial Locations
    US Oncology Central Monitoring
    University of Texas Southwestern Medical Center UTSW 4
    Texas Oncology, P.A. TX Onc Baylor
    Texas Oncology, P.A. Texas Oncology - Amarillo
    Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    US Oncology Central Monitoring
    Dallas, Texas 75246
    Metastatic Breast Cancer
    Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
    The University of Texas Southwestern Medical Center
    Dallas, Texas 75390
    Ovarian Cancer, Cancer of Ovary, Cancer of the Ovary, Ovary Neoplasms, Primary Peritoneal Carcinoma
    Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide
    University of Texas Southwestern
    Dallas, Texas 75390
    Breast Cancer, Obesity
    Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
    Mary Crowley Cancer Research Center
    Dallas, Texas 75246
    Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer
    Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
    Dallas Surgical Group
    Dallas, Texas 75235
    Melanoma
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Texas Health Presbyterian Hospital Dallas

    Trial Locations
    Texas Health Presbyterian Hospital Dallas
    Texas Oncology PA
    Texas Oncology Methodist Charlton Cancer Center
    Texas Cancer Center - Medical City Dallas
    Breast Cancer
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
    Texas Oncology, PA

    Trial Locations
    Texas Oncology, PA
    Texas Oncology-Medical City Dallas
    Texas Oncology- Baylor, Charles A. Sammons Cancer Center
    Extensive-Stage Small Cell Lung Cancer
    Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Tumors, Neoplasms, Cancer
    Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Advanced Cancers, DLBCL, Lymphoma
    An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
    UT Southwestern Medical Center, Simmons Cancer Center
    Dallas, Texas 75390
    Leukemia, Myeloid, Acute
    A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology
    Texas Oncology PA
    Chronic Lymphocytic Leukemia
    A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation
    Texas Oncology, P.A. Central Austin CancerCenter(2)

    Trial Locations
    Texas Oncology, P.A. Central Austin CancerCenter(2)
    Baylor College of Medicine Baylor Texas Oncology
    Breast Cancer
    A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
    Call for Information (Investigational Site 0118)
    Dallas, Texas 75390
    Chronic Lymphocytic Leukemia (CLL)
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    University of Texas Southwestern Medical Center UT southwest
    Dallas, Texas 75390-8527
    Cushing's Disease
    Electronic-Measurement Based Care for Major Depressive Disorder
    The University of Texas Southwestern Medical Center
    Dallas, Texas 75390
    Major Depressive Disorder
    Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
    Investigational Site Number 840003
    Dallas, Texas 75230
    Neoplasm Malignant
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    University of Texas Southwestern Medical Center
    Dallas, Texas
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma
    Investigational Site Number 840003
    Dallas, Texas 75230
    Neoplasm Malignant